Admescope

Admescope, part of the Symeres organization, is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with premium quality tailor-made services to drug discovery in the area of ADME-Tox. Admescopes unique expertise lies in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions and quantitative bioanalysis. The right level of research can always be found for the customer whether in the discovery or lead optimization phase. All of the services include comprehensive study consulting which enables tailoring the study according to customers specific needs. The state-of-art quality data is ensured by optimizing...

Drug metabolism,metabolite profiling & id,lc/ms techniques,drug-drug interactions,dmpk,pharmacokinetics,quantitative bioanalysis,and integrated drug discovery

Admescope operates in the Biotechnology research industry.

Admescope's revenue is 11m - 100m

Admescope has 11 - 50 employees.